← Leaderboards
William E. Van Nostrand
University Of Southern California
$22,540,435
Attributed
$31,790,515
Total exposure
26
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,790,515 · 26
By mechanism
R01$20,719,604 · 11
RF1$5,995,848 · 2
R21$4,235,808 · 10
R56$393,541 · 1
R33$236,375 · 1
P01$209,339 · 1
Top collaborators
- Steven Owen Smith18 shared
- John K Robinson8 shared
- Lisa M Miller6 shared
- Helene D Benveniste5 shared
- Brenda J Anderson2 shared
- Maiken Nedergaard2 shared
- Allen R Tannenbaum2 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainAmyloidProteinsPathologyDepositionBlood VesselsAmyloid Beta-ProteinInsightPeptidesCerebrumCerebral Amyloid AngiopathyMouse ModelDementiaTransgenic MiceCerebrovascularBasePathologicSenile PlaquesAmyloid DepositionMutationLaboratoriesIn Vitro
Grant awards (80)
Impact of SARS-Cov-2 on a Rat Model Cerebral Amyloid Angiopathy$236,250
R21 · FY2025 · AG · contact PI
Impact of ApoE in Novel Rat Models of Late-Onset AD$236,250
R21 · FY2025 · AG · contact PI
Impact of ApoE in Novel Rat Models of Late-Onset AD$196,875
R21 · FY2024 · AG · contact PI
Impact of SARS-Cov-2 on a Rat Model Cerebral Amyloid Angiopathy$196,875
R21 · FY2024 · AG · contact PI
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease$626,621
R01 · FY2022 · AG
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)$624,955
R01 · FY2022 · NS · contact PI
Novel Gene-Edited Rat Model for Development of CAA$452,594
R21 · FY2022 · NS · contact PI
Novel Knock in Mutation Rat Model for CARASIL$443,069
R21 · FY2022 · AG · contact PI
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)$634,556
R01 · FY2021 · NS · contact PI
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease$626,621
R01 · FY2021 · AG
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)$643,743
R01 · FY2020 · NS · contact PI
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease$626,621
R01 · FY2020 · AG
The Role of Copper in Cerebral Amyloid Angiopathy$383,750
R01 · FY2020 · NS · contact PI
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy$383,750
R01 · FY2020 · NS · contact PI
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)$652,534
R01 · FY2019 · NS · contact PI
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease$626,621
R01 · FY2019 · AG
Thrombin: A therapeutic target for cerebral amyloid angiopathy$422,125
R21 · FY2019 · NS · contact PI
The Role of Copper in Cerebral Amyloid Angiopathy$383,750
R01 · FY2019 · NS · contact PI
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy$383,750
R01 · FY2019 · NS · contact PI
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)$660,379
R01 · FY2018 · NS · contact PI
Structural Identification and Functional Consequences of Different Amyloid Strains in Alzheimer's Disease$656,371
R01 · FY2018 · AG
The Role of Copper in Cerebral Amyloid Angiopathy$383,750
R01 · FY2018 · NS · contact PI
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy$383,750
R01 · FY2018 · NS · contact PI
Modeling aerobic exercise regimens: prevention and amelioration of amyloid pathologies and cognitive impairment$314,675
R01 · FY2018 · AG · contact PI
The Role of Copper in Cerebral Amyloid Angiopathy$397,082
R01 · FY2017 · NS · contact PI
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy$325,513
R01 · FY2017 · NS · contact PI
Modeling aerobic exercise regimens: prevention and amelioration of amyloid pathologies and cognitive impairment$314,675
R01 · FY2017 · AG · contact PI
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy$69,487
R01 · FY2017 · NS · contact PI
The Role of Copper in Cerebral Amyloid Angiopathy$1
R01 · FY2017 · NS · contact PI
Characterizing the glymphatic peri-vascular connectome and its disruption in AD$3,370,180
RF1 · FY2016 · AG
Structural Markers for Alzheimer's Disease and Cerebral Amyloid Angiopathy$2,548,256
RF1 · FY2016 · AG
Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy$395,000
R01 · FY2016 · NS · contact PI
The Role of Copper in Cerebral Amyloid Angiopathy$395,000
R01 · FY2016 · NS · contact PI
Modeling aerobic exercise regimens: prevention and amelioration of amyloid pathologies and cognitive impairment$323,900
R01 · FY2016 · AG · contact PI
Transgenic Rat Model of Cerebral Amyloid Angiopathy$237,000
R21 · FY2016 · NS · contact PI
Characterizing the glymphatic peri-vascular connectome and its disruption in AD$77,412
RF1 · FY2016 · AG
Modeling aerobic exercise regimens: prevention and amelioration of amyloid pathologies and cognitive impairment$323,900
R01 · FY2015 · AG · contact PI
Transgenic Rat Model of Cerebral Amyloid Angiopathy$197,500
R21 · FY2015 · NS · contact PI
N-terminus of sAPP Regulates Abeta Assembly$234,630
R21 · FY2014 · NS · contact PI
AbetaPP Influences Cerebral Thrombosis$393,541
R56 · FY2013 · NS · contact PI
Mouse Model of Myelin Basic Protein-Amyloid Beta Interactions in Brain$236,375
R33 · FY2013 · AG · contact PI
Influence of myelin basic protein on neuronal A Beta assembly and toxicity$227,922
R21 · FY2013 · NS · contact PI
N-terminus of sAPP Regulates Abeta Assembly$196,927
R21 · FY2013 · NS · contact PI
Influence of myelin basic protein on neuronal A Beta assembly and toxicity$196,250
R21 · FY2012 · NS · contact PI
Mouse Model of Myelin Basic Protein-Amyloid Beta Interactions in Brain$166,367
R21 · FY2012 · AG · contact PI
Mouse Model of Myelin Basic Protein-Amyloid Beta Interactions in Brain$144,037
R21 · FY2011 · AG · contact PI
Pathological Influence of Vasculotropic Mutant Amyloid-Beta$87,125
R21 · FY2011 · AG · contact PI
Pathologic Interactions of Amyloid Beta-Protein$50,000
R01 · FY2011 · NS · contact PI
Pathologic Interactions of Amyloid Beta-Protein$535,717
R01 · FY2010 · NS · contact PI
Amyloid Beta Protein Precursor Influences Cerebral Thrombosis$377,578
R01 · FY2010 · NS · contact PI
Cerebral Microvascular Amyloid: Neuroinflammation and Cognitive Deficits$334,026
R01 · FY2010 · NS · contact PI
Pathological Influence of Vasculotropic Mutant Amyloid-Beta$198,173
R21 · FY2010 · AG · contact PI
Pathologic Interactions of Amyloid Beta-Protein$531,513
R01 · FY2009 · NS · contact PI
Amyloid Beta Protein Precursor Influences Cerebral Thrombosis$370,283
R01 · FY2009 · NS · contact PI
Cerebral Microvascular Amyloid: Neuroinflammation and Cognitive Deficits$337,399
R01 · FY2009 · NS · contact PI
Pathological Influence of Vasculotropic Mutant Amyloid-Beta$165,839
R21 · FY2009 · AG · contact PI
Amyloid Beta Protein Precursor Influences Cerebral Thrombosis$359,501
R01 · FY2008 · NS · contact PI
Cerebral Microvascular Amyloid: Neuroinflammation and Cognitive Deficits$337,399
R01 · FY2008 · NS · contact PI
Amyloid Beta Protein Precursor Influences Cerebral Thrombosis$359,494
R01 · FY2007 · NS · contact PI
Cerebral Microvascular Amyloid: Neuroinflammation and Cognitive Deficits$337,399
R01 · FY2007 · NS · contact PI
ABetaPP Influences Cerebral Thrombosis$372,723
R01 · FY2006 · NS · contact PI
Transgenic Model for Cerebral Amyloid Angiopathy$349,038
R01 · FY2006 · NS · contact PI
AbetaPP and Cerebral Vasculopathy$293,927
R01 · FY2006 · HL · contact PI
Transgenic Model for Cerebral Amyloid Angiopathy$357,438
R01 · FY2005 · NS
AbetaPP and Cerebral Vasculopathy$301,000
R01 · FY2005 · HL
Transgenic Model for Cerebral Amyloid Angiopathy$357,438
R01 · FY2004 · NS
AbetaPP and Cerebral Vasculopathy$301,000
R01 · FY2004 · HL
Cerebrovascular AB Interactions with Its Precursor$301,000
R01 · FY2004 · NS
Transgenic Model for Cerebral Amyloid Angiopathy$357,438
R01 · FY2003 · NS
Cerebrovascular AB Interactions with Its Precursor$301,000
R01 · FY2003 · NS
AbetaPP and Cerebral Vasculopathy$301,000
R01 · FY2003 · HL
Transgenic Model for Cerebral Amyloid Angiopathy$357,438
R01 · FY2002 · NS
Cerebrovascular AB Interactions with Its Precursor$301,000
R01 · FY2002 · NS
CEREBROVASCULAR SMOOTH MUSCLE CELL MECHANISMS OF AMYLOIDOSIS$0
P01 · FY2002 · AG
Cerebrovascular AB Interactions with Its Precursor$301,000
R01 · FY2001 · NS
BETA AND ITS PRECURSOR INFLUENCE HEMOSTATIC ENZYMES$248,803
R01 · FY2001 · HL
CEREBROVASCULAR SMOOTH MUSCLE CELL MECHANISMS OF AMYLOIDOSIS$0
P01 · FY2001 · AG
BETA AND ITS PRECURSOR INFLUENCE HEMOSTATIC ENZYMES$241,558
R01 · FY2000 · HL
CEREBROVASCULAR SMOOTH MUSCLE CELL MECHANISMS OF AMYLOIDOSIS$209,339
P01 · FY2000 · AG
TRANSGENIC MODEL FOR CEREBRAL AMYLOYD ANGIOPATHY$205,739
R01 · FY2000 · NS